coadministered cagrilintide and semaglutide in adults with overweight or obesity the REDEFINE 2 phase 3a trial involving diabetes, the use of cagrilintide–semaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Weight Loss Efficacy of Cagrilintide

Herbal supplements and over-the-counter medications may also interact with this formulation

Semaglutide increases insulin sensitivity, which means that your body uses insulin more effectively

But the drugs come with menopause-like symptoms, which make them difficult for some women to tolerate

Recommendation 4 is widely used in clinical practice, yet there is insufficient high-level evidence to support its effectiveness, specifically within the Korean population

Clinical studies have shown that the use of semaglutide leads to a significant reduction in body fat, which is crucial for individuals who are obese or overweight with related conditions such as hypertension, dyslipidemia, or sleep apnea